Last updated July 5th 2017
June 27, 2017 | Israeli personalized diets startup DayTwo has raised $12 million in a Series A round of financing led by Johnson & Johnson Innovation. This investment brings the company’s total funding to $17 million. Founded in 2015 and led by CEO Lihi Segal, DayTwo uses individuals’ gut bacteria to create personalized nutrition. The new funds will help expand the company’s product, engineering, and data science teams in Tel Aviv and San Francisco while also supporting its research with the Mayo Clinic and other clinical partners.